While p53 pathway mutation was downstream of most of the other pathway mutations in lung adenocarcinoma, it was at the upstream of all signaling pathway mutations in lung squamous cell carcinoma (Fig. 6 and Fig. 7). This evidence concerns the gene TP53 and squamous cell lung carcinoma.